AU2002309668A1 - Methods for determining the prognosis for cancer patients using tucan - Google Patents

Methods for determining the prognosis for cancer patients using tucan

Info

Publication number
AU2002309668A1
AU2002309668A1 AU2002309668A AU2002309668A AU2002309668A1 AU 2002309668 A1 AU2002309668 A1 AU 2002309668A1 AU 2002309668 A AU2002309668 A AU 2002309668A AU 2002309668 A AU2002309668 A AU 2002309668A AU 2002309668 A1 AU2002309668 A1 AU 2002309668A1
Authority
AU
Australia
Prior art keywords
tucan
prognosis
determining
methods
cancer patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002309668A
Inventor
John C. Reed
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanford Burnham Prebys Medical Discovery Institute
Original Assignee
Sanford Burnham Prebys Medical Discovery Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanford Burnham Prebys Medical Discovery Institute filed Critical Sanford Burnham Prebys Medical Discovery Institute
Publication of AU2002309668A1 publication Critical patent/AU2002309668A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002309668A 2001-05-07 2002-05-07 Methods for determining the prognosis for cancer patients using tucan Abandoned AU2002309668A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US28923301P 2001-05-07 2001-05-07
US60/289,233 2001-05-07
US35693402P 2002-02-12 2002-02-12
US60/356,934 2002-02-12
PCT/US2002/014487 WO2002090931A2 (en) 2001-05-07 2002-05-07 Methods for determining the prognosis for cancer patients using tucan

Publications (1)

Publication Number Publication Date
AU2002309668A1 true AU2002309668A1 (en) 2002-11-18

Family

ID=26965529

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002309668A Abandoned AU2002309668A1 (en) 2001-05-07 2002-05-07 Methods for determining the prognosis for cancer patients using tucan

Country Status (2)

Country Link
AU (1) AU2002309668A1 (en)
WO (1) WO2002090931A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1996940B1 (en) 2006-02-09 2011-12-21 University of South Florida Detection of cancer by elevated levels of bcl-2

Also Published As

Publication number Publication date
WO2002090931A3 (en) 2004-07-01
WO2002090931A2 (en) 2002-11-14

Similar Documents

Publication Publication Date Title
AU2002360766A1 (en) Methods for cancer imaging
AU2002310044A1 (en) Headwall
AU2002247304A1 (en) Anti-neovasculature preparations for cancer
AUPR395801A0 (en) Antibodies against cancer
AU2003224076A1 (en) Antibody combination useful for tumor therapy
AU2001273503A1 (en) A method for prognosing cancer and the proteins involved
AU1465801A (en) Methods for cancer prognosis and diagnosis
AU2002307466A1 (en) Method for detecting breast cancer cells
AU2002258597A1 (en) Prognostic methods for breast cancer
AU2002327860A1 (en) Diagnostic methods
AU2002308642A1 (en) Methods for treating cancer
AU2003202205A1 (en) Methods for identifying cancer risk
AU2003270351A1 (en) Anesthetic-state determining
AU2003272964A1 (en) Remedy for hormone-dependent cancer
AU2003283339A1 (en) Cancer therapy determination
AU2002309668A1 (en) Methods for determining the prognosis for cancer patients using tucan
AU2002360815A1 (en) Human breast cancer biomarkers
AU2002358279A1 (en) Biomarkers for breast cancer
AU2003294272A1 (en) Methods for diagnosing the presence or stage of cancer
AUPR862901A0 (en) Meter removal detector
AU2003223317A1 (en) Determining cancer aggressiveness
AU2002327870A1 (en) Method for diagnosing cancer susceptibility
AU2002358914A1 (en) Cancer prognosis using thymosin beta10 (tbeta10)
AU2003271457A1 (en) Methods for detecting prostate cancer
AU2002347777A1 (en) Methods for determining oligosaccharide binding

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase